You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

WALTHAM, Mass., Aug. 3, 2020 /PRNewswire/ --Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate virtually in the BTIG Biotechnology Conference on Monday, August 10, 2020 at 12:00 p.m. ET. A live webcast of the fireside chat can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the event will also be available for a limited time. About Syndax Pharmaceuticals, Inc. Syndax Pharmaceuticalsis a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the MeninMLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor. For more information, please visitwww.syndax.comor follow the Company onTwitterandLinkedIn. Syndax Contacts Investor ContactMelissa ForstArgot Partners[emailprotected]Tel 212.600.1902 Media ContactTed Held[emailprotected] Tel 212.798.9842 SNDX-G SOURCE Syndax Pharmaceuticals, Inc. Related Links http://www.syndax.com

Answer: Syndax Announces Participation in BTIG Virtual Biotechnology Conference